The human monkeypox virus, belonging to the genus Orthopoxvirus of the family Potyviridae, is a double-stranded deoxyribonucleic acid (DNA) virus. As of June 9, 2022, more than 1,000 people in nearly 30 countries worldwide have been confirmed to be infected with the monkeypox virus.
2022 Global monkeypox outbreak
Although the monkeypox virus is endemic in many African countries, its incidence in these countries has generally been quite low. However, the past two decades have witnessed a dramatic increase in the number of cases of human monkeypox, surpassing the statistics collected in the first 45 years since its first discovery.
The virus has two genetic clades, including the West African and Central African clades. Although all confirmed cases of monkeypox from the current outbreak have been confirmed to belong to the West African clade, none of these cases have been associated with travel to an endemic area.
Rather, these cases have been identified primarily, but not exclusively, among men who have love with men (MSM) who were receiving health care services at primary and with love health clinics. Nevertheless, the extent of local transmission of the monkeypox virus during the current outbreak remains unclear due to current limitations in its surveillance. Global health organizations such as the World Health Organization (WHO) estimate that additional cases of monkeypox infection will be identified in non-endemic countries.
Because transmission of the monkeypox virus is usually a rare event in individuals with no history of travel to an endemic area, prompt identification, and treatment of infected individuals is important to limit further transmission. There is an urgent need for isolation as well as effective contact tracing. Virus.
Importantly, previous reports have indicated that infection with the West African clade generally causes less severe disease than with the Central African (Congo Basin) clade. Moreover, the mortality rates of these clades are estimated to be 3.6% and 10.6%, respectively.
To date, not a single death has been reported in the current monkeypox outbreak. Nevertheless, as WHO expects additional cases of monkeypox to be identified in the future, it is important that countries around the world initiate effective surveillance strategies to reduce the further spread of the virus.
These efforts should also include raising awareness of the current outbreak in potentially affected communities. Additionally, some countries may consider giving smallpox vaccines to individuals who have been in close contact with an infected person, as well as to certain vulnerable populations such as healthcare workers, as a preventive measure.
Transmission of monkeypox virus to humans
Monkeypox virus infection in humans is still unclear. While aerosol transmission to animals has been confirmed, direct or indirect contact with infected animals or their carcasses has been implicated in cases of animal-to-human transmission. Aerosol transmission is also a risk to veterinary professionals and hospital staff.
Rats are often hunted for food, as they provide a protein-rich dietary alternative to the poor. Unfortunately, these animals are carriers of the monkeypox virus.
The incidence of monkeypox infection is usually highest in people living near forests and in regions where smallpox eradication programs have not been vaccinated, and reduced as a result of reduced cross-immunity in younger age groups. Was given. These mechanisms have been implicated in increasing the number of humanitarian cases in Central and West Africa.
Another major contributing factor to the human spread of monkeypox infection is the increased contact of humans with small mammals. Encroachment of forest areas, civil wars, migration of refugees, deforestation and cultivation, climate change, demographic changes, and population change are blamed for this.
The pathogen can invade through broken skin, respiratory tract, or mucous membranes. Human-to-human transmission is also not uncommon through contact with respiratory droplets or bodily fluids, wounds, contaminated surfaces, or vomited.
Cross-immunity and protection
The vaccines virus vaccine protects against monkeypox disease. Moreover, neutralizing antibodies induced by these vaccines are responsible for the underlying immunologic mechanism of such cross-protection. In addition to humans, monkeys also benefit from smallpox vaccines, as they offer protective effects against monkeypox.
In 1978, the widespread introduction of the smallpox vaccine was withdrawn. Subsequently, cross-protective immunity against orthopoxviruses has declined, particularly in the younger generation who remain unvaccinated and susceptible to these viruses. These factors are likely to contribute to the increased number of cases and further transmission of the virus.
Clinical features
The clinical signs and symptoms of this infection are similar to those of smallpox in terms of onset, duration, and skin sites involved.
The incubation period for the monkeypox virus ranges from five to 21 days, with symptoms usually lasting two to five weeks. Symptoms of monkeypox virus infection include fever, chills, lethargy, Athena, headache, back pain, myalgic, and lymph node swelling.
A rash is a primary symptom of this infection, with lesions of various sizes that usually begin to appear on the face and later spread throughout the body. The rash develops into muscles, pa pules, vesicles, and then pustules and usually resolves with the formation of crusts and scabs, which resolve spontaneously when healed. And areas of skin hyperpigmentation are also common.
Additional symptoms of this infection are inflammation of the pharyngeal, conjunctival, and genital mucosa. Clinically, the symptoms and lesions are mild and indistinguishable from smallpox. However, the mortality rate is 1-10%, which may be more significant in children and immunocompromised adults.
Complications of monkeypox virus infection include secondary infection, respiratory distress, encephalitis, a corneal infection that can cause vision loss, and gastrointestinal disturbances, which can include vomiting and diarrhea with dehydration. The clinical presentation of individuals infected with the monkeypox virus who have not received smallpox vaccination is more severe and is associated with higher mortality.
Different diagnoses
Differentiation between chickenpox, monkeypox, and herpesvirus infections remains clinically difficult during epidemics. As a result of the non-specific symptoms of monkeypox infection, many other diseases and conditions must also be ruled out. These may include molluscan contagious, bacterial skin infections, scabies, syphilis, measles, Ricketts infections, anthrax, and drug reactions.
The lesions of monkeypox infection differ from those of chickenpox in their distribution and extent of skin invasion, which is more significant with monkeypox lesions. Additionally, chickenpox lesions tend to be denser on the trunk rather than spread over the entire face and limbs as in monkeypox. A clinically distinct symptom of monkeypox infection is lymphadenopathy.
Diagnosis of this infection is often based on clinical signs and investigations. These include viral culture of pharyngeal or nasopharyngeal swabs and laboratory analysis of skin samples and secretions from lesions.
Other diagnostic methods include skin biopsy, molecular analysis, and sequencing by electron microscopy culture and polymerase chain reaction (PCR), serology testing to detect monkey-specific immunoglobulin M (IGM), as well as histology and immunohistochemistry. Can be included.
Treatment
There is no specific treatment for monkeypox infection. Management aims to relieve symptoms and provide supportive care. This may also include the treatment of secondary bacterial infections in complicated cases.
In 2022, the US Food and Drug Administration (FDA) approved covariate, also known as EPOXY or ST-246, for the treatment of human smallpox disease caused by the Mariola virus in both adults and children. Gave Although tecovirimat is not approved for the treatment of other orthopoxvirus infections, the United States Centers for Disease Control and Prevention (CDC) allows this agent to be used for the treatment of orthodox infections, including monkeypox. Pox, both in adults and children of all ages. Are at high risk of severe disease or are currently experiencing severe complications of this infection.
Prevention
Precautions should include limiting contact with rodents, banning direct exposure to blood and body fluids and undercooked meat, curbing the bushmeat trade, and spreading awareness of the dangers of consuming wild animals.
Stronger health awareness efforts are needed, and the use of protective equipment in vulnerable populations needs to be reinvigorated. In addition, infection control measures are of utmost importance, especially for health care professionals, with immunization against smallpox.
Suspected cases should be isolated in a negative air pressure isolation room. Additionally, contact and droplet precautions are also essential.
Read in Urdu Here
You must be logged in to post a comment.